X4 Pharmaceuticals, Inc
SEC Filing List
XFOR CIK: 0001501697
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Gold Kelly | X4 Pharmaceuticals, Inc | 07/01/2026 | |
| 4 | Statement of changes in beneficial owner... | Kirske David | X4 Pharmaceuticals, Inc | 07/01/2026 | |
| 8-K | Current report filing | X4 Pharmaceuticals, Inc | 07/01/2026 | ||
| 3 | Initial statement of beneficial ownershi... | Gold Kelly | X4 Pharmaceuticals, Inc | 07/01/2026 | |
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |||
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 05/14/2026 | ||
| 8-K/A | Amendment to Current report filing | X4 Pharmaceuticals, Inc | 05/13/2026 | ||
| 4 | Statement of changes in beneficial owner... | Kirske David | X4 Pharmaceuticals, Inc | 05/13/2026 | |
| CORRESP | A correspondence can be sent as a docume... | X4 Pharmaceuticals, Inc | 05/12/2026 | ||
| 144 | Filing for proposed sale of securities u... | 05/12/2026 | |||
| No record found. | |||||
| Load More | |||||
